| Website | aicuris.com |
| Category | BioTech |
| Employees | |
| Description | Infectious Diseas BioPharma Company |
| TOTAL | $74.8M |
| VENTURE FUNDING TOTAL | $74.8M |
| Series B, 4/10 Espirito Santo Ventures Bayer Healthcare | $74.8M |
AiCuris is a clinical-stage biopharmaceutical company focused on resistance breaking antiviral and antibacterial therapeutics targeting Human Cytomegalovirus, Herpes simplex, HIV, Hepatitis B and C and multi-resistant bacteria.
